Actionable news
All posts from Actionable news
Actionable news in CYTK: Cytokinetics, Incorporated,

Stock Update (NASDAQ:CYTK): Cytokinetics, Inc. Announces Results From COSMIC-HF to be Presented in Late Breaking Clinical Trial Session at AHA Scientific Sessions


Cytokinetics, Inc. (NASDAQ:CYTK) announced that results from the expansion phase of COSMIC-HF (ChronicOral Study of Myosin Activation to Increase Contractility in Heart Failure), a Phase 2 trial evaluatingomecamtiv mecarbil in patients with chronic heart failure, will be presented in the Late Breaking Clinical Trial Session at the American Heart Association Scientific Sessions 2015 on November 8 in Orlando, FL.

Clinical Presentation:

Date: Sunday, November 8, 2015

Session Time: 3:45-5:00 p.m. ET (Hall D)

Presentation Time: 4:31-4:40 p.m. ET

Session: LBCT.01 Failure is Not an Option: New Drugs and Systems of Care

Presentation Title: Chronic Oral Study of...